Loading...
Considerations for payers in managing hormone receptor-positive advanced breast cancer
Breast cancer (BC) is the second most common cause of death in women. In 2010, the direct cost associated with BC care in the US was $16.5 billion, the highest among all cancers. By the year 2020, at the current rates of incidence and survival, the cost is projected to increase to approximately $20...
Na minha lista:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove Medical Press
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4096457/ https://ncbi.nlm.nih.gov/pubmed/25031542 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEOR.S57214 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|